186 related articles for article (PubMed ID: 31960496)
1. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S; Giura MT; Viola R; Ramondetta A; Siliquini N; Cardone P; Tonella L; Quaglino P; Dapavo P; Panzone M; Ortoncelli M; Fierro MT
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e380-e383. PubMed ID: 31960496
[No Abstract] [Full Text] [Related]
2. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data.
de Wijs LEM; Bosma AL; Erler NS; Hollestein LM; Gerbens LAA; Middelkamp-Hup MA; Kunkeler ACM; Nijsten TEC; Spuls PI; Hijnen DJ
Br J Dermatol; 2020 Feb; 182(2):418-426. PubMed ID: 31145810
[TBL] [Abstract][Full Text] [Related]
4. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Fargnoli MC; Esposito M; Ferrucci S; Girolomoni G; Offidani A; Patrizi A; Peris K; Costanzo A; Malara G; Pellacani G; Romanelli M; Amerio P; Cristaudo A; Flori ML; Motolese A; Betto P; Patruno C; Pigatto P; Peccianti C; Stinco G; Zalaudek I; Bianchi L; Boccaletti V; Cannavo SP; Cusano F; Lembo S; Mozzillo R; Gallo R; Potenza C; Rongioletti F; Tiberio R; Grieco T; Micali G; Persechino S; Pettinato M; Pucci S; Stingeni L; Caruso C; Argenziano G;
J Dermatolog Treat; 2022 Mar; 33(2):1146-1149. PubMed ID: 32436765
[No Abstract] [Full Text] [Related]
5. Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience.
Simonetti O; Radi G; Diotallevi F; Molinelli E; Rizzetto G; Offidani A
Clin Exp Dermatol; 2021 Jul; 46(5):939-940. PubMed ID: 33576497
[No Abstract] [Full Text] [Related]
6. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre.
Olesen CM; Holm JG; Nørreslet LB; Serup JV; Thomsen SF; Agner T
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1562-1568. PubMed ID: 30959559
[TBL] [Abstract][Full Text] [Related]
7. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis.
Nettis E; Patella V; Lombardo C; Detoraki A; Macchia L; Di Leo E; Carbonara M; Canonica GW; Bonzano L
Allergy; 2020 Oct; 75(10):2653-2661. PubMed ID: 32424957
[TBL] [Abstract][Full Text] [Related]
9. Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry".
Seo HM; Oh SU; Park SK; Kim JS
J Am Acad Dermatol; 2021 Sep; 85(3):e171. PubMed ID: 33667539
[No Abstract] [Full Text] [Related]
10. Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
Bosma AL; de Wijs LEM; Hof MH; van Nieuwenhuizen BR; Gerbens LAA; Middelkamp-Hup MA; Hijnen D; Spuls PI
J Am Acad Dermatol; 2021 Sep; 85(3):e173-e174. PubMed ID: 33675862
[No Abstract] [Full Text] [Related]
11. A single-centre real-life experience on effectiveness and safety of dupilumab in adolescents with severe atopic dermatitis in treatment with cyclosporine A.
Colonna C; Zussino M; Ponziani A; Gelmetti C; Monzani NA
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e533-e535. PubMed ID: 33872419
[No Abstract] [Full Text] [Related]
12. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Bosma AL; Spuls PI; Garcia-Doval I; Naldi L; Prieto-Merino D; Tesch F; Apfelbacher CJ; Arents BWM; Barbarot S; Baselga E; Deleuran M; Eichenfield LF; Gerbens LAA; Irvine AD; Manca A; Mendes-Bastos P; Middelkamp-Hup MA; Roberts A; Seneschal J; Svensson Å; Thyssen JP; Torres T; Vermeulen FM; Vestergaard C; von Kobyletzki LB; Wall D; Weidinger S; Schmitt J; Flohr C
Br J Dermatol; 2020 Jun; 182(6):1423-1429. PubMed ID: 31444799
[TBL] [Abstract][Full Text] [Related]
13. Angioedema: A potential complication of dupilumab in atopic dermatitis.
Fritz AL; Lacy FA; Morrell DS
Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
[TBL] [Abstract][Full Text] [Related]
14. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.
Agache I; Akdis CA; Akdis M; Brockow K; Chivato T; Del Giacco S; Eiwegger T; Eyerich K; Giménez-Arnau A; Gutermuth J; Guttman-Yassky E; Maurer M; Ogg G; Ong PY; O'Mahony L; Schwarze J; Warner A; Werfel T; Palomares O; Jutel M
Allergy; 2021 Apr; 76(4):988-1009. PubMed ID: 33538044
[TBL] [Abstract][Full Text] [Related]
15. Polyenthesitis during treatment with dupilumab for atopic dermatitis.
Ishibashi M; Honda T; Tabuchi Y; Kabashima K
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e319-e321. PubMed ID: 31991016
[No Abstract] [Full Text] [Related]
16. Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.
Nettis E; Fabbrocini G; Ortoncelli M; Pellacani G; Argenziano G; Di Leo E; Patruno C; Stingeni L; Foti C; Rongioletti F; Macchia L; Tavecchio S; Napolitano M; Ribero S; Bonzano L; Calabrese G; Di Bona D; Nisticò SP; Hansel K; Romita P; Piras V; Carbonara M; Detoraki A; Ferrucci SM
Br J Dermatol; 2021 Mar; 184(3):561-563. PubMed ID: 32998177
[No Abstract] [Full Text] [Related]
17. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
[TBL] [Abstract][Full Text] [Related]
18. Development of arthralgia during treatment with dupilumab in a patient with atopic dermatitis.
Arakawa N; Inoue T; Tanji T; Amano H
J Dermatol; 2021 Aug; 48(8):e397-e398. PubMed ID: 33991014
[No Abstract] [Full Text] [Related]
19. A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab.
Patruno C; Ferrillo M; Fabbrocini G; Napolitano M
Dermatol Ther; 2021 Jan; 34(1):e14556. PubMed ID: 33205854
[No Abstract] [Full Text] [Related]
20. Dupilumab for atopic dermatitis.
Pediatr Dermatol; 2021 Nov; 38(6):1559-1560. PubMed ID: 34931365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
